These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 8005132)

  • 1. Adenosine-induced non-sustained polymorphic ventricular tachycardia.
    Romer M; Candinas R
    Eur Heart J; 1994 Feb; 15(2):281-2. PubMed ID: 8005132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Exogenous adenosine as an anti-arrhythmia agent].
    Tebbenjohanns J; Pfeiffer D; Schumacher B; Korte T; Jung W; Lüderitz B
    Z Kardiol; 1996; 85 Suppl 6():191-9. PubMed ID: 9064965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tachycardias: considerations in childhood in the 90s].
    Gutiérrez-Larraya F; Jabón A
    An Esp Pediatr; 1993 Dec; 39(6):475-88. PubMed ID: 8166400
    [No Abstract]   [Full Text] [Related]  

  • 4. [Efficacy of adenosine triphosphate in terminating supraventricular tachycardia].
    Schläpfer J; Fromer M; Kappenberger L
    Schweiz Med Wochenschr; 1993 May; 123(18):941-4. PubMed ID: 8497781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supraventricular tachycardia: diagnosis and treatment.
    Dreifus LS; Hessen SE
    Cardiology; 1990; 77(3):259-68. PubMed ID: 2272062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine and the treatment of supraventricular tachycardia.
    Rankin AC; Brooks R; Ruskin JN; McGovern BA
    Am J Med; 1992 Jun; 92(6):655-64. PubMed ID: 1605147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine-induced tachycardia: what is the mechanism?
    Vora A; Lokhandwala Y
    J Cardiovasc Electrophysiol; 2000 Apr; 11(4):491-2. PubMed ID: 10809507
    [No Abstract]   [Full Text] [Related]  

  • 8. Adenosine in treating cardiac arrhythmias.
    Zehender M; Jeron A; Faber T; Brunner M; Just H
    J Auton Pharmacol; 1996 Dec; 16(6):329-31. PubMed ID: 9131409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Terminating supraventricular tachycardia with adenosine--comparing the effectiveness of 12 mg and 18 mg].
    Weismüller P; Kattenbeck K; Heinroth KM; Ranke C; Trappe HJ
    Dtsch Med Wochenschr; 2000 Aug; 125(33):961-9. PubMed ID: 10994404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia.
    DiMarco JP; Sellers TD; Berne RM; West GA; Belardinelli L
    Circulation; 1983 Dec; 68(6):1254-63. PubMed ID: 6640877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine triphosphate and adenosine: perspectives in the acute management of paroxysmal supraventricular tachycardia.
    Belhassen B; Pelleg A
    Clin Cardiol; 1985 Sep; 8(9):460-4. PubMed ID: 4042450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of non-invasive transdermal stimulation of the heart in selecting an anti-arrhythmia drug in a patient with supraventricular paroxysmal tachycardia with a re-entry mechanism within the atrioventricular node].
    Prochaczek F; Gałecka J; Becker A
    Kardiol Pol; 1988; 31(6):337-42. PubMed ID: 3236620
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical and electrophysiologic effects of magnesium sulfate on paroxysmal supraventricular tachycardia and comparison with adenosine triphosphate.
    Viskin S; Belhassen B; Sheps D; Laniado S
    Am J Cardiol; 1992 Oct; 70(9):879-85. PubMed ID: 1529941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supraventricular tachycardia in children.
    Van der Merwe DM; Van der Merwe PL
    Cardiovasc J S Afr; 2004; 15(2):64-9. PubMed ID: 15148540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine-induced tachycardia acceleration: an unusual proarrhythmia.
    Singh V; Salehi N; Thakur RK
    BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25628324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of symptomatic atrial fibrillation in patients with paroxysmal supraventricular tachycardia.
    Hamer ME; Wilkinson WE; Clair WK; Page RL; McCarthy EA; Pritchett EL
    J Am Coll Cardiol; 1995 Apr; 25(5):984-8. PubMed ID: 7897142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiologic and clinical effects of flecainide for recurrent paroxysmal supraventricular tachycardia.
    Hoff PI; Tronstad A; Oie B; Ohm OJ
    Am J Cardiol; 1988 Sep; 62(9):585-9. PubMed ID: 3137798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Termination of paroxysmal supraventricular tachycardia by tecadenoson (CVT-510), a novel A1-adenosine receptor agonist.
    Prystowsky EN; Niazi I; Curtis AB; Wilber DJ; Bahnson T; Ellenbogen K; Dhala A; Bloomfield DM; Gold M; Kadish A; Fogel RI; Gonzalez MD; Belardinelli L; Shreeniwas R; Wolff AA
    J Am Coll Cardiol; 2003 Sep; 42(6):1098-102. PubMed ID: 13678937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of parenteral magnesium sulfate in the treatment of patients with reentrant AV supraventricular tachycardia.
    Sager PT; Widerhorn J; Petersen R; Leon C; Ryzen E; Rude R; Rahimtoola SH; Bhandari AK
    Am Heart J; 1990 Feb; 119(2 Pt 1):308-16. PubMed ID: 2301220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine as a therapeutic agent.
    Mosqueda-Garcia R
    Clin Invest Med; 1992 Oct; 15(5):445-55. PubMed ID: 1458718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.